Search details
1.
TAVR: nemesis of NOACs?
J Thromb Thrombolysis
; 55(1): 181-184, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36318378
2.
High On-Treatment Platelet Reactivity: Aspirin versus Clopidogrel.
Pharmacology
; 108(1): 83-89, 2023.
Article
in English
| MEDLINE | ID: mdl-36463859
3.
Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1.
Circ Res
; 126(4): 486-500, 2020 02 14.
Article
in English
| MEDLINE | ID: mdl-31859592
4.
Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus.
Diabetologia
; 64(8): 1834-1849, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34131781
5.
Aspirin I.V. Loading during Elective Percutaneous Coronary Intervention.
Pharmacology
; 106(11-12): 682-686, 2021.
Article
in English
| MEDLINE | ID: mdl-34350898
6.
MTX Treatment Does Not Improve Outcome in Mice with AMI.
Pharmacology
; 106(3-4): 225-232, 2021.
Article
in English
| MEDLINE | ID: mdl-33221800
7.
A novel mechanism of ACE inhibition-associated enhanced platelet reactivity: disproof of the ARB-MI paradox?
Eur J Clin Pharmacol
; 76(9): 1245-1251, 2020 Sep.
Article
in English
| MEDLINE | ID: mdl-32500252
8.
Platelet reactivity in patients with chronic kidney disease and hemodialysis.
J Thromb Thrombolysis
; 49(1): 168-172, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31691067
9.
Enhanced Platelet Reactivity under Aspirin Medication and Major Adverse Cardiac and Cerebrovascular Events in Patients with Coronary Artery Disease.
Pharmacology
; 105(1-2): 118-122, 2020.
Article
in English
| MEDLINE | ID: mdl-31639801
10.
Platelet Reactivity in Patients on Aspirin and Clopidogrel Therapy Measured by a New Bedside Whole-Blood Assay.
J Cardiovasc Pharmacol
; 73(1): 40-47, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30383606
11.
Dose reduction, oral application, and order of intake to preserve aspirin antiplatelet effects in dipyrone co-medicated chronic artery disease patients.
Eur J Clin Pharmacol
; 75(1): 13-20, 2019 Jan.
Article
in English
| MEDLINE | ID: mdl-30251061
12.
Malondialdehyde Assay in the Evaluation of Aspirin Antiplatelet Effects.
Pharmacology
; 103(1-2): 23-29, 2019.
Article
in English
| MEDLINE | ID: mdl-30355919
13.
Safety and Efficacy in Prasugrel- Versus Ticagrelor-Treated Patients With ST-Elevation Myocardial Infarction.
J Cardiovasc Pharmacol
; 72(4): 186-190, 2018 10.
Article
in English
| MEDLINE | ID: mdl-29985284
14.
Response by Petzold et al to Letter Regarding Article, "Rivaroxaban Reduces Arterial Thrombosis by Inhibition of Fxa-Driven Platelet Activation via Protease Activated Receptor-1".
Circ Res
; 126(10): e116-e117, 2020 05 08.
Article
in English
| MEDLINE | ID: mdl-32379578
15.
Response by Petzold et al to Letter Regarding Article, "Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1".
Circ Res
; 126(8): e54-e55, 2020 04 10.
Article
in English
| MEDLINE | ID: mdl-32271680
16.
Diabetes mellitus is not associated with enhanced bleeding risk in patients after percutaneous coronary intervention.
Diabet Med
; 38(5): e14532, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33511685
17.
Rivaroxaban reduces thromboxane induced platelet aggregation - the forgotten compass arm?
Platelets
; 32(8): 1126-1128, 2021 11 17.
Article
in English
| MEDLINE | ID: mdl-33788669
18.
Heparin dosing in patients with Impella-supported cardiogenic shock.
Int J Cardiol
; 399: 131690, 2024 Mar 15.
Article
in English
| MEDLINE | ID: mdl-38160912
19.
Sphingosine-1-phosphate improves outcome of no-reflow acute myocardial infarction via sphingosine-1-phosphate receptor 1.
ESC Heart Fail
; 10(1): 334-341, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36217778
20.
Revealing concealed cardioprotection by platelet Mfsd2b-released S1P in human and murine myocardial infarction.
Nat Commun
; 14(1): 2404, 2023 04 26.
Article
in English
| MEDLINE | ID: mdl-37100836